InsidersTradesSigma
Track the Blueberries Medical Corp. stock price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares are quoted on the CA market, under the oversight of SEDI. Operating in the Healthcare & Pharma sector, Blueberries Medical Corp. has recorded 29 reports. Market capitalisation: €7.4m. The latest transaction was reported on 27 August 2026 (16 - Acquisition or disposition under a prospectus exemption). Among the most active insiders: Rodriguez, Guillermo Pablo. Every trade is openly available.
29
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,137 of 29,062 companies
22.0
score / 100
Value11
Quality33
FCF yld-17%
Earn yld-22%
EV/EBITDA·
ROE-158%
Gross mgn47%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 August 2026
Declarations29 total
84,230,769 shares@ CA$0.013Common SharesTSXSEDI:4769189
Canonical exit: 24 Nov 2026 (T+90)
10,000 shares@ CA$0.010.0010% mcap2.4% of flowCommon SharesTSXSEDI:4759028
Canonical exit: 2 Nov 2026 (T+90)
20,000 shares@ CA$0.00810.0016% mcap3.9% of flowCommon SharesTSXSEDI:4759024
Canonical exit: 2 Nov 2026 (T+90)
30,000 shares@ CA$0.00830.0025% mcap6.1% of flowCommon SharesTSXSEDI:4759019
Canonical exit: 2 Nov 2026 (T+90)
30,000 shares@ CA$0.00840.0025% mcap6.1% of flowCommon SharesTSXSEDI:4759016
Canonical exit: 2 Nov 2026 (T+90)
20,000 shares@ CA$0.010.0020% mcap4.9% of flowCommon SharesTSXSEDI:4759001
Canonical exit: 1 Nov 2026 (T+90)
10,000 shares@ CA$0.01020.0010% mcap3.2% of flowCommon SharesTSXSEDI:4757754
Canonical exit: 28 Oct 2026 (T+90)
10,000 shares@ CA$0.01160.0016% mcap3.8% of flowCommon SharesTSXSEDI:4753746
Canonical exit: 14 Oct 2026 (T+90)
10,000 shares@ CA$0.01390.0019% mcap4.8% of flowCommon SharesTSXSEDI:4752451
Canonical exit: 11 Oct 2026 (T+90)
10,000 shares@ CA$0.01390.0019% mcap5.0% of flowCommon SharesTSXSEDI:4751248
Canonical exit: 5 Oct 2026 (T+90)
10,000 shares@ CA$0.00970.0013% mcap3.5% of flowCommon SharesTSXSEDI:4751246
Canonical exit: 5 Oct 2026 (T+90)
5,000 shares@ CA$0.00970.0006% mcap1.7% of flowCommon SharesTSXSEDI:4751242
Canonical exit: 5 Oct 2026 (T+90)
10,000 shares@ CA$0.010.0012% mcap4.0% of flowCommon SharesTSXSEDI:4742309
Canonical exit: 28 Sept 2026 (T+90)
20,000 shares@ CA$0.00890.0022% mcap7.1% of flowCommon SharesTSXSEDI:4742308
Canonical exit: 28 Sept 2026 (T+90)
15,000 shares@ CA$0.00850.0016% mcap5.1% of flowCommon SharesTSXSEDI:4742307
Canonical exit: 28 Sept 2026 (T+90)
10,000 shares@ CA$0.01120.0014% mcap4.4% of flowCommon SharesTSXSEDI:4742306
Canonical exit: 28 Sept 2026 (T+90)
10,000 shares@ CA$0.00840.0010% mcap3.3% of flowCommon SharesTSXSEDI:4742305
Canonical exit: 28 Sept 2026 (T+90)
10,000 shares@ CA$0.01130.0015% mcap5.9% of flowCommon SharesTSXSEDI:4739390
Canonical exit: 21 Sept 2026 (T+90)
5,000 shares@ CA$0.00890.0006% mcap2.3% of flowCommon SharesTSXSEDI:4739389
Canonical exit: 21 Sept 2026 (T+90)
20,000 shares@ CA$0.01010.0027% mcap10.5% of flowCommon SharesTSXSEDI:4739388
Canonical exit: 20 Sept 2026 (T+90)
5,000 shares@ CA$0.00920.0006% mcap2.4% of flowCommon SharesTSXSEDI:4739387
Canonical exit: 20 Sept 2026 (T+90)
5,000 shares@ CA$0.00930.0006% mcap2.4% of flowCommon SharesTSXSEDI:4739386
Canonical exit: 20 Sept 2026 (T+90)
1,000 shares@ CA$0.00860.0001% mcap0.5% of flowCommon SharesTSXSEDI:4739385
Canonical exit: 8 Sept 2026 (T+90)
10,000 shares@ CA$0.010.0012% mcap6.9% of flowCommon SharesTSXSEDI:4737346
Canonical exit: 14 Sept 2026 (T+90)
20,000 shares@ CA$0.00990.0025% mcap14.7% of flowCommon SharesTSXSEDI:4734576
Canonical exit: 8 Sept 2026 (T+90)
25 of 29 declarations
关于 Blueberries Medical Corp.
Blueberries Medical Corp. 是一家在加拿大上市的公司，在加拿大初级市场拥有历史，与 CSE/TSX Venture 生态系统相关联，股票代码为 BBM，其运营足迹主要在哥伦比亚。对于欧洲和加拿大的法语投资者来说，该公司最好被理解为一个具有拉丁美洲风险敞口、监管复杂性高、以出口为导向的商业模式的大麻医疗和衍生品公司。该公司表示，它持有哥伦比亚相关部委颁发的生产、加工和商业化具有不同 THC 特性的大麻产品所需的许可证，其核心业务集中在哥伦比亚中部的波哥大萨凡纳地区。 Blueberries Medical 的根源可追溯到 2019 年 CDN MSolar 和 Blueberries Cannabis Corp. 的业务合并，此次合并创建了 Blueberries Medical Corp. 并将业务带入加拿大公开市场。自那时以来，该公司已将自己定位为拉丁美洲药用大麻和衍生产品的生产商。其运营模式是垂直整合的，围绕种植、提取、标准化、配方和商业化构建。该公司目前的产品组合侧重于干花提取、非精神活性成分、水溶性 CBD、THC 树脂和馏分、复合配方、CBD/THC 花，以及涵盖食品、健康、化妆品和治疗应用的使用案例。 从竞争角度来看，Blueberries 旨在利用科学技术、生产成本优势和分销协议，作为大麻衍生品在多个终端市场的国际供应商。然而，该业务仍然是一个高度受监管且仍在发展中的利基行业中的小众运营商，执行风险与生产规模扩大、合规性、渠道开发和客户采用相关。公司最近的披露表明，除了核心大麻平台之外，公司持续推动产品多元化，包括在 2025 年 4 月首次向国内兽药实验室进行商业销售，这表明公司正在努力扩大收入基础并提高其提取和配方能力的商业相关性。 从地理上看，该公司仍然以哥伦比亚为基础，同时寻求区域和国际市场。其通过 SEDAR+ 和公司通讯进行的最新披露表明，正在进行产品开发、商业化努力和战略合作伙伴关系，旨在将平台扩展到纯原材料模式之外。对于加拿大的 TSX/TSXV 投资者而言，股权案例主要与公司将获得许可的哥伦比亚生产资产转化为可重复销售、确保符合法规的市场准入以及建立更多元化的大麻相关和邻近健康产品组合的能力相关。简而言之，Blueberries Medical 是一个具有国际抱负的小盘专业健康和大麻平台，但仍需要严格执行才能将运营能力转化为可持续盈利能力。
